Zsófia Váradi

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Karolina Nemes, Monika Csóka, Noémi Nagy et al. · Pathology & Oncology Research · 2014 · 56 citations

Hematological Malignancy, Tumor Biology, Medicine +9

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease

Zsófia Váradi, Rita Bánusz, Judit Csomor et al. · OncoTargets and Therapy · 2017 · 42 citations · Full text

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Ágnes Márk, Melinda Hajdú, Zsófia Váradi et al. · BMC Cancer · 2013 · 39 citations · Full text

Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)

Karolina Nemes, Anna Sebestyén, Ágnes Márk et al. · PLoS ONE · 2013 · 27 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Increased Mtor Activity +16

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Anna Sebestyén, T. Sticz, Ágnes Márk et al. · Modern Pathology · 2012 · 24 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +6